Suppr超能文献

尿调节蛋白p.Cys147Trp突变通过激活内质网应激和细胞凋亡导致肾脏疾病。

Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis.

作者信息

Johnson Bryce G, Dang Lan T, Marsh Graham, Roach Allie M, Levine Zebulon G, Monti Anthony, Reyon Deepak, Feigenbaum Lionel, Duffield Jeremy S

机构信息

Research and Development, Biogen, Cambridge, Massachusetts, USA.

Department of Medicine, University of Washington, Seattle, Washington, USA.

出版信息

J Clin Invest. 2017 Nov 1;127(11):3954-3969. doi: 10.1172/JCI93817. Epub 2017 Oct 9.

Abstract

Uromodulin-associated kidney disease (UAKD) is caused by mutations in the uromodulin (UMOD) gene that result in a misfolded form of UMOD protein, which is normally secreted by nephrons. In UAKD patients, mutant UMOD is poorly secreted and accumulates in the ER of distal kidney epithelium, but its role in disease progression is largely unknown. Here, we modeled UMOD accumulation in mice by expressing the murine equivalent of the human UMOD p.Cys148Trp point mutation (UmodC147W/+ mice). Like affected humans, these UmodC147W/+ mice developed spontaneous and progressive kidney disease with organ failure over 24 weeks. Analysis of diseased kidneys and purified UMOD-producing cells revealed early activation of the PKR-like ER kinase/activating transcription factor 4 (PERK/ATF4) ER stress pathway, innate immune mediators, and increased apoptotic signaling, including caspase-3 activation. Unexpectedly, we also detected autophagy deficiency. Human cells expressing UMOD p.Cys147Trp recapitulated the findings in UmodC147W/+ mice, and autophagy activation with mTOR inhibitors stimulated the intracellular removal of aggregated mutant UMOD. Human cells producing mutant UMOD were susceptible to TNF-α- and TRAIL-mediated apoptosis due to increased expression of the ER stress mediator tribbles-3. Blocking TNF-α in vivo with the soluble recombinant fusion protein TNFR:Fc slowed disease progression in UmodC147W/+ mice by reducing active caspase-3, thereby preventing tubule cell death and loss of epithelial function. These findings reveal a targetable mechanism for disease processes involved in UAKD.

摘要

尿调节蛋白相关肾病(UAKD)由尿调节蛋白(UMOD)基因突变引起,该突变导致UMOD蛋白错误折叠,而UMOD蛋白通常由肾单位分泌。在UAKD患者中,突变的UMOD分泌不佳并积聚在远端肾上皮的内质网中,但其在疾病进展中的作用很大程度上尚不清楚。在此,我们通过表达与人类UMOD p.Cys148Trp点突变等效的小鼠模型(UmodC147W/+小鼠)来模拟小鼠体内UMOD的积聚。与受影响的人类一样,这些UmodC147W/+小鼠在24周内出现了自发性进行性肾病并伴有器官衰竭。对患病肾脏和纯化的产生UMOD的细胞进行分析发现,蛋白激酶R样内质网激酶/激活转录因子4(PERK/ATF4)内质网应激途径、先天性免疫介质早期激活,以及包括半胱天冬酶-3激活在内的凋亡信号增加。出乎意料的是,我们还检测到自噬缺陷。表达UMOD p.Cys147Trp的人类细胞重现了UmodC147W/+小鼠中的发现,用mTOR抑制剂激活自噬可刺激细胞内聚集的突变UMOD的清除。由于内质网应激介质TRIB3的表达增加,产生突变UMOD的人类细胞易受TNF-α和TRAIL介导的凋亡影响。用可溶性重组融合蛋白TNFR:Fc在体内阻断TNF-α可减缓UmodC147W/+小鼠的疾病进展,其机制是减少活性半胱天冬酶-3,从而防止肾小管细胞死亡和上皮功能丧失。这些发现揭示了UAKD相关疾病过程中的一种可靶向治疗的机制。

相似文献

引用本文的文献

4
Endoplasmic reticulum stress in diseases.疾病中的内质网应激
MedComm (2020). 2024 Aug 26;5(9):e701. doi: 10.1002/mco2.701. eCollection 2024 Sep.
5
Advances in uromodulin biology and potential clinical applications.尿调蛋白生物学研究进展及其潜在的临床应用
Nat Rev Nephrol. 2024 Dec;20(12):806-821. doi: 10.1038/s41581-024-00881-7. Epub 2024 Aug 19.

本文引用的文献

3
Therapeutic Targeting of Autophagy.自噬的治疗靶向。
EBioMedicine. 2016 Dec;14:15-23. doi: 10.1016/j.ebiom.2016.10.034. Epub 2016 Oct 23.
5
Insights into kidney diseases from genome-wide association studies.从全基因组关联研究看肾脏疾病。
Nat Rev Nephrol. 2016 Sep;12(9):549-62. doi: 10.1038/nrneph.2016.107. Epub 2016 Aug 1.
7
Therapeutic targeting of autophagy in myocardial infarction and heart failure.心肌梗死和心力衰竭中自噬的治疗靶点
Expert Rev Cardiovasc Ther. 2016 Sep;14(9):1007-19. doi: 10.1080/14779072.2016.1202760. Epub 2016 Jun 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验